BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28554737)

  • 1. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.
    Zhang H; Nair V; Saha J; Atkins KB; Hodgin JB; Saunders TL; Myers MG; Werner T; Kretzler M; Brosius FC
    Kidney Int; 2017 Oct; 92(4):909-921. PubMed ID: 28554737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease.
    Dieter BP; Meek RL; Anderberg RJ; Cooney SK; Bergin JL; Zhang H; Nair V; Kretzler M; Brosius FC; Tuttle KR
    PLoS One; 2019; 14(2):e0211555. PubMed ID: 30763329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor 1 knockdown attenuates high glucose-induced podocyte injury by promoting the JAK2/STAT signalling-mediated autophagy.
    Zhang Y; Liu M; Wu Y; Xu Y; Hong Y; Xiang H
    Nephrology (Carlton); 2024 Jul; 29(7):394-404. PubMed ID: 38586891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
    Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
    Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
    Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
    Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
    Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
    Zhou G; Cheung AK; Liu X; Huang Y
    Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
    Berthier CC; Zhang H; Schin M; Henger A; Nelson RG; Yee B; Boucherot A; Neusser MA; Cohen CD; Carter-Su C; Argetsinger LS; Rastaldi MP; Brosius FC; Kretzler M
    Diabetes; 2009 Feb; 58(2):469-77. PubMed ID: 19017763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
    Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
    Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
    Ma X; Schwarz A; Sevilla SZ; Levin A; Hultenby K; Wernerson A; Lal M; Patrakka J
    J Am Soc Nephrol; 2018 Jun; 29(6):1679-1689. PubMed ID: 29636387
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
    Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
    J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
    Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
    J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
    Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
    J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.
    Carlson EC; Chhoun JM; Laturnus DI; Bikash KC; Berg B; Zheng S; Epstein PN
    Diabetes Metab Res Rev; 2013 Feb; 29(2):113-24. PubMed ID: 22926941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.